Heparin-like inhibitor of blood coagulation in normal newborn.

Blood coagulation and fibrinolysis during normal pregnancy.

Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.

Disseminated intravascular coagulation in the newborn.

Lipoprotein-associated coagulation inhibitor.

Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.

Care of the normal newborn.

Discovery of glycyrrhetinic acid as an orally active, direct inhibitor of blood coagulation factor xa.

Quality control in blood coagulation.

Basic mechanisms in blood coagulation.

Blood coagulation and fibrinolysis of the newborn viewed as perinatal factors. II. Finbrinolytic studies in the respiratory distress syndrome of the newborn infant.

Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.

Normal total plasma calcium in the newborn.

Membrane and lipid involvement in blood coagulation.

Membrane asymmetry and blood coagulation.

[Proceedings: Blood coagulation studies in prostaglandin abortion].

[Routine preoperative diagnosis of blood coagulation?].

Ultrasonic measurement of blood coagulation time.

Molecular and cellular biology of blood coagulation.

Evolutionary assembly of blood coagulation proteins.

A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.

Submaximal blood flow and blood viscosity in newborn infants.

Red blood cell transfusion in newborn infants.

Gut blood flow velocities in the newborn.

Doppler ultrasound studies in renal arteries of normal newborn babies.

Suggest Documents

Blood coagulation and fibrinolysis during normal pregnancy.

Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.

Disseminated intravascular coagulation in the newborn.

Lipoprotein-associated coagulation inhibitor.

Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.

Care of the normal newborn.

Discovery of glycyrrhetinic acid as an orally active, direct inhibitor of blood coagulation factor xa.

Quality control in blood coagulation.

Basic mechanisms in blood coagulation.

Blood coagulation and fibrinolysis of the newborn viewed as perinatal factors. II. Finbrinolytic studies in the respiratory distress syndrome of the newborn infant.

Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.

Normal total plasma calcium in the newborn.

Membrane and lipid involvement in blood coagulation.

Membrane asymmetry and blood coagulation.

[Proceedings: Blood coagulation studies in prostaglandin abortion].

[Routine preoperative diagnosis of blood coagulation?].

Ultrasonic measurement of blood coagulation time.

Molecular and cellular biology of blood coagulation.

Evolutionary assembly of blood coagulation proteins.

A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.

Submaximal blood flow and blood viscosity in newborn infants.

Red blood cell transfusion in newborn infants.

Gut blood flow velocities in the newborn.

Doppler ultrasound studies in renal arteries of normal newborn babies.

Heparin-like inhibitor of blood coagulation in normal newborn.

Recommend Documents

Follow Us